Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8174 items from SEC EDGAR · clear filters
- 8-K - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)
Automated noteAgilent Technologies filed a Form 8-K on September 8, 2026 reporting director and officer departures, elections, appointments and related compensation arrangements, and providing a Regulation FD disclosure together with financial statements and exhibits.
- 8-K - Health Catalyst, Inc. (0001636422) (Filer)
Automated noteHealth Catalyst, Inc. filed a Form 8-K on September 8, 2026 reporting director and officer departures, elections, appointments and related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - OCEANEERING INTERNATIONAL INC (0000073756) (Filer)
Automated noteOceaneering International Inc. filed a Form 8-K on September 8 2026, including Item 7.01, a Regulation FD disclosure.
- 8-K - Structure Therapeutics Inc. (0001888886) (Filer)
Automated noteStructure Therapeutics Inc. filed a Form 8-K on September 8, 2026 (Accession No. 0001104659-26-105688, 7 MB), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - PATTERSON UTI ENERGY INC (0000889900) (Filer)
Automated notePatterson UTI Energy Inc filed a Form 8-K on September 8, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Azitra, Inc. (0001701478) (Filer)
Automated noteAzitra, Inc. filed a Form 8-K on September 8 2026, which includes a Regulation FD disclosure (Item 7.01) and the company's financial statements and related exhibits (Item 9.01).
- 8-K - DPC Holdings PLC (0002107018) (Filer)
Automated noteDPC Holdings PLC filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Spyre Therapeutics, Inc. (0001636282) (Filer)
Automated noteSpyre Therapeutics filed a Form 8-K on September 8 2026, including Regulation FD disclosure, other events, and financial statements and exhibits.
- 8-K - 1606 CORP. (0001877461) (Filer)
Automated note1606 Corp filed a Form 8-K on September 8, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - Arrive AI Inc. (0001818274) (Filer)
Automated noteArrive AI Inc. filed a Form 8-K on September 8, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.
- 8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)
Automated noteRelmada Therapeutics, Inc. filed a Form 8-K with the SEC on September 8, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001213900-26-097851, 187 KB).
- 8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
Automated noteLongevity Health Holdings, Inc. filed a Form 8-K on September 8, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001437749-26-029755.
- 8-K - Strategy Inc (0001050446) (Filer)
Automated noteStrategy Inc. filed a Form 8-K with the SEC on September 8, 2026, disclosing information under Item 7.01 (Regulation FD) and reporting other events under Item 8.01.
- 8-K - Definium Therapeutics, Inc. (0001813814) (Filer)
Automated noteDefinium Therapeutics, Inc. filed a Form 8-K on September 8 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Sana Biotechnology, Inc. (0001770121) (Filer)
Automated noteSana Biotechnology filed a Form 8-K on September 8, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Strive, Inc. (0001920406) (Filer)
Automated noteStrive, Inc. filed a Form 8-K reporting an Item 8.01 “Other Events” on September 8, 2026, with accession number 0001628280-26-060809.
- 8-K - GENERAL ELECTRIC CO (0000040545) (Filer)
Automated noteGeneral Electric filed a Form 8-K on September 8, 2026, including Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - GROUP 1 AUTOMOTIVE INC (0001031203) (Filer)
Automated noteGroup 1 Automotive Inc. filed a Form 8-K on September 8, 2026, including Item 2.02 (results of operations and financial condition), Item 8.01 (other events), and Item 9.01 (financial statements and exhibits).
- 8-K - IonQ, Inc. (0001824920) (Filer)
Automated noteIonQ, Inc. filed a Form 8-K with the SEC on September 8, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.
- 8-K - Pyxis Oncology, Inc. (0001782223) (Filer)
Automated notePyxis Oncology filed a Form 8-K reporting director and officer departures, appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - NABORS INDUSTRIES LTD (0001163739) (Filer)
Automated noteNabors Industries Ltd filed a Form 8-K on September 8 2026, including a Regulation FD Disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Philip Morris International Inc. (0001413329) (Filer)
Automated notePhilip Morris International Inc. filed a Form 8-K on September 8 2026, including a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - enGene Therapeutics Inc. (0001980845) (Filer)
Automated noteenGene Therapeutics Inc. filed a Form 8-K on September 8, 2026, including Item 2.02 covering results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - UNITED COMMUNITY BANKS INC (0000857855) (Filer)
Automated noteUnited Community Banks Inc filed a Form 8-K on September 8, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Soluna Holdings, Inc (0000064463) (Filer)
Automated noteSoluna Holdings, Inc. filed a Form 8-K on September 8 2026, including a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Rigetti Computing, Inc. (0001838359) (Filer)
Automated noteRigetti Computing, Inc. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer)
Automated noteX4 Pharmaceuticals filed a Form 8-K on September 8, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)
Automated noteTonix Pharmaceuticals Holding Corp. filed a Form 8-K on September 8 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001493152-26-041689.
- 8-K - ABM INDUSTRIES INC /DE/ (0000771497) (Filer)
Automated noteABM Industries Inc. filed a Form 8-K on September 8, 2026, including Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits).
- 8-K - KIORA PHARMACEUTICALS INC (0001372514) (Filer)
Automated noteKiora Pharmaceuticals filed a Form 8-K on September 8 2026, reporting director/officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.